Gemcitabine‐Induced Thrombotic Microangiopathy in Patient With Homozygous Deletion in CFHR1‐CFHR3
Case Reports in Oncological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crom/6253969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Oncological Medicine, online erschienen am 24.03.2026. Verfasst von Natasha Dziarnowski und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We present here the case of a 66‐year‐old female with a history of pancreatic adenocarcinoma who was on a chemotherapeutic regimen of nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) and gemcitabine after demonstrating local progression of her disease on the regimen of 5‐fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX). The patient presented to clinic prior to receiving Cycle 15 of nab‐paclitaxel and gemcitabine with labs demonstrating concern for acute kidney injury and hemolytic anemia. The patient was referred for admission with renal biopsy exhibiting endothelial injury and thrombotic microangiopathy (TMA). Additionally, the patient was found to have mutations in a TMA genetic panel, raising questions on whether an existing genetic predisposition contributed to the development of gemcitabine‐induced TMA. The patient was treated with eculizumab with resolution of TMA and without relapse after three infusions.
Zitieren
APA
Dziarnowski, N., Puglisi, M., Baralo, B., & Vachhani, H. (2026). Gemcitabine‐Induced Thrombotic Microangiopathy in Patient With Homozygous Deletion in CFHR1‐CFHR3. Case Reports in Oncological Medicine, 2026(1). https://doi.org/10.1155/crom/6253969
Vancouver
Dziarnowski N, Puglisi M, Baralo B, Vachhani H. Gemcitabine‐Induced Thrombotic Microangiopathy in Patient With Homozygous Deletion in CFHR1‐CFHR3. Case Reports in Oncological Medicine. 2026;2026(1). doi:10.1155/crom/6253969
BibTeX
@article{Dziarnowski2026,
author = {Dziarnowski, Natasha and Puglisi, Morgan and Baralo, Bohdan and Vachhani, Hetal},
title = {Gemcitabine‐Induced Thrombotic Microangiopathy in Patient With Homozygous Deletion in CFHR1‐CFHR3},
journal = {Case Reports in Oncological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crom/6253969}
}
EUVIMED